Genomic and transcriptomic correlates of clinical benefit from immunotherapy and targeted therapy among patients with metastatic renal cell carcinoma (mRCC).

被引:0
作者
Salgia, Nicholas
Dizman, Nazli
Lyou, Yung
Bergerot, Paulo Gustavo
Hsu, Joann
Byron, Sara Ann
Trent, Jeffrey M.
Pal, Sumanta K.
机构
[1] City Hope Comprehens Canc Ctr, Duarte, CA USA
[2] Translat Genom Res Inst, Phoenix, AZ USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5076
引用
收藏
页数:2
相关论文
empty
未找到相关数据